SNIPR

SNIPR is making CRISPR-based precision medicines to target the world’s superbugs

[SNIPR @sniprbiome]

We're excited to have @wholelysedup, our Director of Phage Engineering, speaking at @VirusOfMicrobes 2026 about SNIPR001 in Prague this week.

Wednesday 8th July 2026 11:45 (15m)
Full program: https://t.co/oOUCneQhEe

#VoM2026

[SNIPR @sniprbiome]

We're hiring a Data Engineer at SNIPR in Copenhagen!

You'd build and maintain the pipelines, databases, and web applications (Python/Django, SQL, AWS) that connect our lab instruments, LIMS, and external data platforms.

Deadline: 2 August 2026

[SNIPR @sniprbiome]

We are hiring a Director of Preclinical Testing to lead our In Vivo Pharmacology and In Vitro & Assays team here in Copenhagen.

Find the full job description and apply via the link below, apply by 17 June 2026. https://t.co/3CvYZ9vpt9

[SNIPR @sniprbiome]

Later this week, our @groendahl will open Day 2 of the @Jafral1 Phage Summit 2026 in Ljubljana as keynote speaker.
The talk will focus on how engineered phage-based therapies are moving from laboratory promise toward clinical reality.

[SNIPR @sniprbiome]

We're hiring a Senior Project Manager with a solid project management toolbox and strong microbiology/bacteriology expertise to help drive key research projects forward in #AMR full details here: https://t.co/aGg8cgbEtK

[Eric van der Helm @EricvdHelm]

Last month, @groendahl and I joined @CARB_X Investor Day in Munich ahead of @ESCMID Global. Always energizing to be among so many teams pushing #AMR innovation forward; from early discovery to clinical-stage programs.

[SNIPR @sniprbiome]

Our CEO @groendahl had the privilege of joining this week's @AdamSmithHouse Dialogue on Market Solutions for #AMR Effectiveness, focused on generic antimicrobials as the load-bearing infrastructure of the AMR response. Thanks for convening such a thoughtful conversation!

[Adam Smith's Panmure House @AdamSmithHouse]

This week we hosted the second dialogue in the Panmure House Dialogues programme: Market Solutions for Antimicrobial Effectiveness (AME).

This session focused on ‘Generic antimicrobials as the crucial load-bearing elements of AME infrastructure’ and brought together a diverse group of contributors spanning biotechnology, clinical practice, microbiology, economics, and investment.

Through a series of panel discussions, participants explored key themes including resilient supply, universal access, and aligned incentives. As global health systems continue to face evolving infectious threats, these conversations are both timely and essential. We are proud to continue Adam Smith’s legacy by convening experts from across sectors to tackle some of today’s most complex challenges.

Thank you to those listed below for sharing their expertise and shaping this discussion. We look forward to publishing the outcomes soon on our Panmure House Perspectives page: https://t.co/EyRE1OZ8wV

Dr Liz Tayler, Professor Mike Sharland, Nobuko Ichikawa, Dr David Jenkins, Dr Melisa Williams Higgins, Maria Souza, David McKinney, Dr Christine Årdal, Dr Ali Cameron, Professor Dominic Moran, Professor W. Brian Arthur, Dr Robert Kimbui, Matthew Ford, Ella Hashemi, Ian Ball, Dr Christian Gröndahl, Dr Henry Skinner, Dr. Alicia Demirjian, Professor Adam Dixon, Dr Lucy Naga

[SNIPR @sniprbiome]

We're hiring a Laboratory Technician to join our Preclinical Testing team in Copenhagen: hands-on work with bacteria, phages, and CRISPR-based medicines. 1-year position, apply by May 3 https://t.co/V0js2q7yXR

[SNIPR @sniprbiome]

🌍 Four events, three cities, one mission for SNIPR. We're excited to be taking our science and story across Europe over the next several days. We'd love to connect. 👋
#CRISPRMED26 #ESCMIDGlobal2026 #CRISPR @CARB_X #SPRIND @ESCMID @SPRIND

[SNIPR @sniprbiome]

We were excited to welcome the production company Nordic Made Film earlier this week to film at SNIPR and interview our CEO @groendahl

The visit is part of a new documentary series, The Microbes That Save Us, highlighting how microbes and cutting-edge biotechnology.

[SNIPR @sniprbiome]

We're at the 8th Annual Bacteriophage Summit in London this week! Tomorrow, Jonas Hink will take the stage to talk about advancing engineered phages toward clinical reality.

📅 Wednesday, 25 March | 4:00 PM

[SNIPR @sniprbiome]

🔗 Read the paper in The Lancet Microbe: https://t.co/wn4p823nJ0
🔗 Full press release: https://t.co/umSVZulOoB
We thank @CARB_X for supporting this work.

[SNIPR @sniprbiome]

Today, we're excited to announce the publication of final Phase 1 results for SNIPR001, our CRISPR therapeutic designed to precisely reduce E. coli in the gut — including multi-drug resistant strains — while preserving healthy gut bacteria.

[SNIPR @sniprbiome]

We’re excited to share real-world lessons from building and translating CRISPR-based antimicrobials - what’s worked, what hasn’t, and what it takes to move from promise to patient impact at the 10th @AMR_Conference . Come meet @EricvdHelm in Basel.

[SNIPR @sniprbiome]

We’re starting the new year fresh with a brand-new website. Take a look and let us know what you think: https://t.co/EhRc9JR0Qe

[SNIPR @sniprbiome]

Job opening: Research Assistant

Are you a skilled scientist early in your career with a passion for bacterial strain engineering and an interest in supporting projects across our research organization? Apply before the 20th of January here: https://t.co/fFkNdYDpNM

[SNIPR @sniprbiome]

We’re excited about where this can go next, including new ways to fight antimicrobial resistance #AMR and proud of the entire SNIPR team for pushing the boundaries of CRISPR biology!

[SNIPR @sniprbiome]

Proud moment for all of us at SNIPR Biome; we’ve just published our research on a novel #CRISPR–Cas system.
Open access link: https://t.co/gAu10AInmP

[SNIPR @sniprbiome]

SNIPR will be in San Francisco for the 44th annual #JPM2026 conference in January. @groendahl and @EricvdHelm will be involved in JPM week events - reach out if you’d like to meet while in town.

[Eric van der Helm @EricvdHelm]

Heading to London for the ⁦@Jefferies⁩ Global Healthcare Conference Nov 17–20. ⁦@sniprbiome⁩ will be on-site, together w. ⁦@groendahl⁩. We’re excited to share insights on our proprietary CRISPR platform and our differentiated #AMR pipeline.

#JefferiesHealthcare